ELV logo

Elevance Health (ELV) Cash From Financing

Annual CFF

-$3.35 B
-$2.03 B-154.10%

31 December 2023

ELV Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

-$915.00 M
-$1.58 B-236.98%

30 September 2024

ELV Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

-$609.00 M
+$79.00 M+11.48%

30 September 2024

ELV TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ELV Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-154.1%+8.0%+81.0%
3 y3 years-30.5%-10.2%+3.2%
5 y5 years-49.4%-735.4%+75.9%

ELV Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-891.7%at low-237.0%+36.0%-244.0%+82.5%
5 y5 years-891.7%at low-127.0%+61.3%-244.0%+82.5%
alltimeall time-236.9%+10.3%-127.0%+61.3%-122.8%+88.6%

Elevance Health Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$915.00 M(-237.0%)
-$609.00 M(-11.5%)
June 2024
-
$668.00 M(+1987.5%)
-$688.00 M(-75.3%)
Mar 2024
-
$32.00 M(-108.1%)
-$2.79 B(-16.8%)
Dec 2023
-$3.35 B(+154.1%)
-$394.00 M(-60.4%)
-$3.35 B(+4.2%)
Sept 2023
-
-$994.00 M(-30.5%)
-$3.21 B(-7.5%)
June 2023
-
-$1.43 B(+169.3%)
-$3.47 B(+60.0%)
Mar 2023
-
-$531.00 M(+105.8%)
-$2.17 B(+64.7%)
Dec 2022
-$1.32 B(-411.6%)
-$258.00 M(-79.4%)
-$1.32 B(-44.5%)
Sept 2022
-
-$1.25 B(+888.2%)
-$2.38 B(+21.8%)
June 2022
-
-$127.00 M(-139.4%)
-$1.95 B(-26.2%)
Mar 2022
-
$322.00 M(-124.5%)
-$2.64 B(-724.8%)
Dec 2021
$423.00 M(-116.5%)
-$1.31 B(+58.4%)
$423.00 M(-167.2%)
Sept 2021
-
-$830.00 M(+1.2%)
-$629.00 M(-19.7%)
June 2021
-
-$820.00 M(-124.2%)
-$783.00 M(-651.4%)
Mar 2021
-
$3.39 B(-243.1%)
$142.00 M(-105.5%)
Dec 2020
-$2.57 B(+13.3%)
-$2.37 B(+140.5%)
-$2.57 B(+70.7%)
Sept 2020
-
-$984.00 M(-1037.1%)
-$1.50 B(+300.0%)
June 2020
-
$105.00 M(-84.5%)
-$376.00 M(-67.5%)
Mar 2020
-
$679.00 M(-152.1%)
-$1.16 B(-48.9%)
Dec 2019
-$2.27 B(+1.1%)
-$1.30 B(-1005.6%)
-$2.27 B(-10.2%)
Sept 2019
-
$144.00 M(-121.3%)
-$2.52 B(-16.1%)
June 2019
-
-$677.00 M(+57.8%)
-$3.01 B(+47.2%)
Mar 2019
-
-$429.00 M(-72.5%)
-$2.04 B(-8.8%)
Dec 2018
-$2.24 B(-624.8%)
-$1.56 B(+359.1%)
-$2.24 B(-227.8%)
Sept 2018
-
-$340.00 M(-218.5%)
$1.75 B(+320.9%)
June 2018
-
$287.00 M(-145.8%)
$416.50 M(-129.0%)
Mar 2018
-
-$627.00 M(-125.8%)
-$1.43 B(-435.9%)
Dec 2017
$427.00 M(-153.4%)
$2.43 B(-245.1%)
$427.00 M(-129.9%)
Sept 2017
-
-$1.68 B(+7.2%)
-$1.43 B(+418.7%)
June 2017
-
-$1.56 B(-226.7%)
-$275.10 M(-132.6%)
Mar 2017
-
$1.23 B(+113.2%)
$844.00 M(-205.6%)
Dec 2016
-$799.00 M(-74.2%)
$579.00 M(-210.4%)
-$799.00 M(-67.9%)
Sept 2016
-
-$524.60 M(+18.0%)
-$2.49 B(-2.7%)
June 2016
-
-$444.70 M(+8.8%)
-$2.56 B(-33.0%)
Mar 2016
-
-$408.70 M(-63.1%)
-$3.81 B(+23.3%)
Dec 2015
-$3.09 B(+69.7%)
-$1.11 B(+86.6%)
-$3.09 B(+23.0%)
Sept 2015
-
-$593.90 M(-65.1%)
-$2.51 B(+1.3%)
June 2015
-
-$1.70 B(-646.0%)
-$2.48 B(+98.2%)
Mar 2015
-
$311.90 M(-159.0%)
-$1.25 B(-31.3%)
Dec 2014
-$1.82 B(+6.1%)
-$528.90 M(-5.7%)
-$1.82 B(-9.8%)
Sept 2014
-
-$560.90 M(+18.3%)
-$2.02 B(+1.2%)
June 2014
-
-$474.10 M(+83.3%)
-$2.00 B(+42.8%)
Mar 2014
-
-$258.60 M(-64.4%)
-$1.40 B(-18.7%)
Dec 2013
-$1.72 B
-$725.80 M(+35.2%)
-$1.72 B(+286.7%)
Sept 2013
-
-$536.80 M(-533.3%)
-$444.20 M(-126.8%)
June 2013
-
$123.90 M(-121.4%)
$1.66 B(-38.0%)
DateAnnualQuarterlyTTM
Mar 2013
-
-$579.10 M(-205.7%)
$2.68 B(+28.1%)
Dec 2012
$2.09 B(-203.5%)
$547.80 M(-65.0%)
$2.09 B(+162.1%)
Sept 2012
-
$1.57 B(+37.2%)
$797.10 M(-249.0%)
June 2012
-
$1.14 B(-197.8%)
-$535.10 M(-77.7%)
Mar 2012
-
-$1.17 B(+56.9%)
-$2.40 B(+18.9%)
Dec 2011
-$2.02 B(-36.3%)
-$744.00 M(-417.8%)
-$2.02 B(-8.8%)
Sept 2011
-
$234.10 M(-132.4%)
-$2.21 B(-2.9%)
June 2011
-
-$723.50 M(-7.9%)
-$2.28 B(-18.4%)
Mar 2011
-
-$785.80 M(-16.4%)
-$2.80 B(-11.7%)
Dec 2010
-$3.17 B(-6.9%)
-$939.80 M(-661.1%)
-$3.17 B(-7.9%)
Sept 2010
-
$167.50 M(-113.5%)
-$3.44 B(-27.3%)
June 2010
-
-$1.24 B(+7.0%)
-$4.73 B(+8.6%)
Mar 2010
-
-$1.16 B(-4.3%)
-$4.35 B(+27.9%)
Dec 2009
-$3.40 B(-8.9%)
-$1.21 B(+7.9%)
-$3.40 B(+16.2%)
Sept 2009
-
-$1.12 B(+29.7%)
-$2.93 B(+8.1%)
June 2009
-
-$864.30 M(+317.7%)
-$2.71 B(+21.3%)
Mar 2009
-
-$206.90 M(-71.9%)
-$2.24 B(-40.2%)
Dec 2008
-$3.74 B(+9.6%)
-$736.70 M(-18.4%)
-$3.74 B(-16.6%)
Sept 2008
-
-$902.50 M(+131.9%)
-$4.48 B(-15.9%)
June 2008
-
-$389.20 M(-77.2%)
-$5.32 B(+15.8%)
Mar 2008
-
-$1.71 B(+15.3%)
-$4.60 B(+34.8%)
Dec 2007
-$3.41 B(-8.5%)
-$1.48 B(-15.3%)
-$3.41 B(+26.6%)
Sept 2007
-
-$1.75 B(-617.9%)
-$2.69 B(+247.1%)
June 2007
-
$337.60 M(-165.0%)
-$775.70 M(-68.5%)
Mar 2007
-
-$519.00 M(-32.0%)
-$2.46 B(-34.0%)
Dec 2006
-$3.73 B(-252.3%)
-$762.70 M(-552.9%)
-$3.73 B(+338.5%)
Sept 2006
-
$168.40 M(-112.5%)
-$849.50 M(+23.7%)
June 2006
-
-$1.35 B(-24.6%)
-$686.70 M(-229.4%)
Mar 2006
-
-$1.79 B(-184.5%)
$530.70 M(-78.3%)
Dec 2005
$2.45 B(+18.6%)
$2.11 B(+537.9%)
$2.45 B(+1.2%)
Sept 2005
-
$331.20 M(-358.3%)
$2.42 B(+19.4%)
June 2005
-
-$128.20 M(-198.1%)
$2.02 B(-6.5%)
Mar 2005
-
$130.70 M(-93.7%)
$2.16 B(+4.9%)
Dec 2004
$2.06 B(-893.0%)
$2.08 B(-3453.9%)
$2.06 B(-2915.0%)
Sept 2004
-
-$62.10 M(-596.8%)
-$73.30 M(-48.1%)
June 2004
-
$12.50 M(-58.6%)
-$141.20 M(-6.9%)
Mar 2004
-
$30.20 M(-156.0%)
-$151.60 M(-41.7%)
Dec 2003
-$260.20 M(-136.7%)
-$53.90 M(-58.5%)
-$260.20 M(-23.4%)
Sept 2003
-
-$130.00 M(-6290.5%)
-$339.50 M(-150.6%)
June 2003
-
$2.10 M(-102.7%)
$670.30 M(+6.3%)
Mar 2003
-
-$78.40 M(-41.1%)
$630.80 M(-11.1%)
Dec 2002
$709.30 M(+1422.1%)
-$133.20 M(-115.1%)
$709.30 M(-15.8%)
Sept 2002
-
$879.80 M(-2452.4%)
$842.50 M(-2358.7%)
June 2002
-
-$37.40 M(<-9900.0%)
-$37.30 M(<-9900.0%)
Mar 2002
-
$100.00 K
$100.00 K
Dec 2001
$46.60 M
-
-

FAQ

  • What is Elevance Health annual cash flow from financing activities?
  • What is the all time high annual CFF for Elevance Health?
  • What is Elevance Health annual CFF year-on-year change?
  • What is Elevance Health quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Elevance Health?
  • What is Elevance Health quarterly CFF year-on-year change?
  • What is Elevance Health TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Elevance Health?
  • What is Elevance Health TTM CFF year-on-year change?

What is Elevance Health annual cash flow from financing activities?

The current annual CFF of ELV is -$3.35 B

What is the all time high annual CFF for Elevance Health?

Elevance Health all-time high annual cash flow from financing activities is $2.45 B

What is Elevance Health annual CFF year-on-year change?

Over the past year, ELV annual cash flow from financing activities has changed by -$2.03 B (-154.10%)

What is Elevance Health quarterly cash flow from financing activities?

The current quarterly CFF of ELV is -$915.00 M

What is the all time high quarterly CFF for Elevance Health?

Elevance Health all-time high quarterly cash flow from financing activities is $3.39 B

What is Elevance Health quarterly CFF year-on-year change?

Over the past year, ELV quarterly cash flow from financing activities has changed by +$79.00 M (+7.95%)

What is Elevance Health TTM cash flow from financing activities?

The current TTM CFF of ELV is -$609.00 M

What is the all time high TTM CFF for Elevance Health?

Elevance Health all-time high TTM cash flow from financing activities is $2.68 B

What is Elevance Health TTM CFF year-on-year change?

Over the past year, ELV TTM cash flow from financing activities has changed by +$2.60 B (+81.05%)